Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

U.S. COVID-19 Mortality Rate Rises

X
Your article was successfully shared with the contacts you provided.

The latest federal COVID-19 Community Profile Report shows the country climbing up a pandemic intensity mountain.

Just about every indicator the report team tracks got worse between the week ending Jan. 3 and the week ending Jan. 10.

Resources

Here’s what happened to some key indicators over that period:

  • Number of New COVID-19 Cases per 100,000 People: 516 (up from 453)
  • Average Number of Hospital Inpatients with COVID-19: 134,394 (up from 128,849)
  • Number of COVID-19 Deaths per 100,000 People: 6.8 (up from 5.6)

Dallas had an especially high COVID-19 hospital admissions rate: 6,161 of its 7.6 million residents ended up in the hospital with confirmed or suspected COVID-19 last week. COVID-19-related hospital admissions were 6% higher than they were the week before.

For hospital intensive care units, the numbers have been especially grim in Riverside California: Patients with COVID-19 filled 63% of staffed adult ICU beds in Riverside, up from 61% the week before.

— Read White House Advisors Report COVID-19 Death Rate Decreaseon ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on FacebookLinkedIn and Twitter.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.